Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening

Methylated SEPT9 showed relatively low sensitivity in detecting early stage colorectal cancer (CRC) and advanced adenomas (AA) in plasma. Combination of multiple biomarkers was an effective strategy to improve sensitivity in early stage cancer diagnosis and screening. A new qPCR‐based assay combinin...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cancer Med
Glavni autori: Zhao, Guodong, Li, Hui, Yang, Zixuan, Wang, Zhenzhen, Xu, Manqiu, Xiong, Shangmin, Li, Shiming, Wu, XiaoTing, Liu, Xiaoyu, Wang, Ziwen, Zhu, Yun, Ma, Yong, Fei, Sujuan, Zheng, Minxue
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2019
Teme:
Clinical Cancer Research
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745865/
https://ncbi.nlm.nih.gov/pubmed/31407497
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2475
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items